Product Images Glycopyrrolate

Glycopyrrolate Injection is a medication used for IM or IV administration containing 0.4mg/2mL glycopyrrolate in a 2mL vial with benzyl alcohol. It is not recommended for newborns and usual dosage should be consulted with the package insert. The medication must be stored at 20°C to 25°C (68°F to 77°F). The original manufacturing NDC code is 0143-9681-25 and the medication can only be obtained with a prescription. The medicine is manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275.*

Glycopyrrolate Injection is a medication that comes in a 2mL vial with a strength of 0.2mg/mL or 0.4mg/2mL. It is packaged in boxes of 25 vials and has a shelf life until 2025-01-01. The medication can be administered via IM or IV but should not be used in newborns. Glycopyrrolate Injection requires storage at 20° to 25°C. The manufacturer's package insert provides more details about usual dosage. The medication should be stored at controlled room temperature between 68°F to 77°F (20°C to 25°C). Glycopyrrolate Injection is only available with a prescription, and the original product is manufactured by HF Acquisition Co., LLC in Mukilteo, Washington.*

This is a description of a medication. The medication is Glycopyrrolate which is available in the form of an injection. The injection contains 0.4mg of the medicine per 2 mL of solution. It is for either IV or IM use. The packaging is in a single-dose vial of 2 mL. The product contains benzyl alcohol. The medication is distributed by West-Ward and the lot number and expiry date are not available.*